Continuous Neuromuscular Blockade and Mortality in Subjects With Exacerbation of Idiopathic Interstitial Pneumonias

References

1. 1.↵
   1. Travis WD,
   2. Costabel U,
   3. Hansell DM,
   4. King TE Jr.,
   5. Lynch DA,
   6. Nicholson AG,
   7. et al

   . An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733–748.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Mallick S

   . Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 2008;102(10):1355–1359.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Raghu G,
   2. Collard HR,
   3. Egan JJ,
   4. Martinez FJ,
   5. Behr J,
   6. Brown KK,
   7. et al

   . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788–824.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Papazian L,
   2. Forel JM,
   3. Gacouin A,
   4. Penot-Ragon C,
   5. Perrin G,
   6. Loundou A,
   7. et al

   . Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107–1116.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Gainnier M,
   2. Roch A,
   3. Forel JM,
   4. Thirion X,
   5. Arnal JM,
   6. Donati S,
   7. Papazian L

   . Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004;32(1):113–119.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Bellani G,
   2. Laffey JG,
   3. Pham T,
   4. Fan E,
   5. Brochard L,
   6. Esteban A,
   7. et al

   . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788–800.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Torbic H,
   2. Bauer SR,
   3. Personett HA,
   4. Dzierba AL,
   5. Stollings JL,
   6. Ryder LP,
   7. et al

   . Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: a multicenter survey. J Crit Care 2017;38:278–283.

   OpenUrl
8. 8.↵
   1. Nava S,
   2. Rubini F

   . Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999;54(5):390–395.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Yasunaga H,
   2. Matsui H,
   3. Horiguchi H,
   4. Fushimi K,
   5. Matsuda S

   . Clinical epidemiology and health services research using the Diagnosis Procedure Combination Database in Japan. Asian Pacific J Dis Manag 2015; 7(1-2):19–24.

   OpenUrl
10. 10.↵
    1. Bramer GR

    . International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 1988;41(1):32–36.

    OpenUrlPubMed
11. 11.↵
    1. Ravi B,
    2. Croxford R,
    3. Austin PC,
    4. Lipscombe L,
    5. Bierman AS,
    6. Harvey PJ,
    7. et al

    . The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis. BMJ 2013;347:f6187.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Ono K,
    2. Wada K,
    3. Takahara T,
    4. Shirotani T

    . Indications for computed tomography in patients with mild head injury. Neurol Med Chir (Tokyo) 2007;47(7):291–297.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Shigemori M,
    2. Abe T,
    3. Aruga T,
    4. Ogawa T,
    5. Okudera H,
    6. Ono J,
    7. et al

    . Guidelines for the management of severe head injury, 2nd edition guidelines from the guidelines committee on the management of severe head injury, the Japan Society of Neurotraumatology. Neurol Med Chir (Tokyo) 2012;52(1):1–30.

    OpenUrlPubMed
14. 14.↵
    1. Zou G

    . A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159(7):702–706.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Rush B,
    2. Wiskar K,
    3. Berger L,
    4. Griesdale D

    . The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis. Respir Med 2016;111:72–76.

    OpenUrl
16. 16.↵
    1. Forel JM,
    2. Roch A,
    3. Marin V,
    4. Michelet P,
    5. Demory D,
    6. Blache JL,
    7. et al

    . Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006;34(11):2749–2757.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Fanelli V,
    2. Morita Y,
    3. Cappello P,
    4. Ghazarian M,
    5. Sugumar B,
    6. Delsedime L,
    7. et al

    . Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-alpha1. Anesthesiology 2016;124(1):132–140.

    OpenUrl
18. 18.↵
    1. Sottile PD,
    2. Kiser TH,
    3. Burnham EL,
    4. Ho PM,
    5. Allen RR,
    6. Vandivier RW,
    7. Moss M

    . An observational study of the efficacy of cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome. Am J Respir Crit Care Med 2018;197(7):897–904.

    OpenUrl
19. 19.↵
    1. Barr J,
    2. Fraser GL,
    3. Puntillo K,
    4. Ely EW,
    5. Gelinas C,
    6. Dasta JF,
    7. et al

    . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263–306.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Collard HR,
    2. Moore BB,
    3. Flaherty KR,
    4. Brown KK,
    5. Kaner RJ,
    6. King TE Jr.,
    7. et al

    . Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176(7):636–643.

    OpenUrlCrossRefPubMedWeb of Science